New hope: An experimental drug promises to slow the progress of Alzheimer's disease

The experimental drug Lecanemab is shown as a "potential" treatment to treat patients diagnosed with Alzheimer's disease.

However, the findings raise some safety concerns due to their association with certain serious adverse events that occurred in some of the patients who participated in the study.

This video takes an in-depth look at this recent scientific finding, its potential risks, and everything you need to know about Alzheimer's.